弥合EGFR/TGF-β信号,绕过免疫检查点阻塞的抵抗
Noura J Choudhury1, Aditi Kothari2, Christine M Bestvina1
1Department of Medicine, University of Chicago, Chicago, Illinois.
概括
与pembrolizumab结合的Ficerasfusp alfa显示出在状癌症中克服抗EGFR疗法的耐药性的承诺. 这种新的组合针对多种致癌途径,解决当前治疗方法的局限性.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 表皮生长因子受体 (EGFR) 是状细胞癌的关键标.
- 抗EGFR单一疗法由于途径激活和瘤异质性而表现出有限的疗效.
- 抵抗机制需要新的治疗策略.
研究的目的:
- 为了研究ficerafusp alfa与pembrolizumab结合的潜力.
- 评估这种组合作为一种克服状癌症抵抗力的战略.
主要方法:
- 临床研究早期阶段.
- 使用一种双功能融合蛋白 (ficerafusp alfa).
- 与 pembrolizumab 的联合治疗.
主要成果:
- 组合疗法代表了克服耐药性的潜在解决方案.
- 早期的临床数据表明,在解决单一疗法的局限性方面具有有效性.
结论:
- 菲克拉斯福斯阿尔法和潘布罗利祖马布联合治疗是一种有希望的方法.
- 这一策略可能会改善抗EGFR治疗抗性状癌症患者的治疗结果.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
9.2K
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.5K
相关概念视频
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
01:15Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K